---
title: Citation Sources and Traceability for Biologics Financial Reports
slug: /en/industry/finance-d014-c105-f009
page_type: Industry scenario page
article_section: Financial Statement Analysis and Reporting
is_part_of: FastGPT Tech Center
meta_title: Citation Sources and Traceability for Biologics Financial
meta_description: Biologics financial report data primarily comes from domestic and overseas stock exchange disclosure platforms, official investor relations pages of
source_type: Industry topic matrix (industry x direction x capability x real community questions)
date_published: 2026-09-15
date_modified: 2026-09-15
---

# Citation Sources and Traceability for Biologics Financial Reports

## What the data for this category looks like
Biologics financial report data primarily comes from domestic and overseas stock exchange disclosure platforms, official investor relations pages of pharmaceutical companies, and third-party industry compliance databases. Update cycles follow fixed schedules. Annual reports must be disclosed by the end of April each year. Semi-annual reports must be disclosed by the end of August. Quarterly reports release at their scheduled deadlines.

Document structures include sections such as R&D pipeline progress, batch issuance data, production capacity, revenue breakdown, R&D investment, and compliance matters. Fields cover batch issuance batch numbers, single-batch output, R&D project numbers, investment amounts, and more. Units include ten thousand yuan, hundred million yuan, batches, units, and others. Some specialized terms must stay in their original form.

## Constraints for the citation sources and traceability link
Biologics financial report data sources are scattered and have clear authority hierarchies. The traceability link must clarify data source priorities to avoid low-reliability data being prioritized for citation.

Fixed update cycles require traceability configurations to align with scheduled synchronization rules. This prevents invalid recalls during non-disclosure periods.

Financial reports use many specialized terms and have dense paragraph data. Traceability must precisely match original document chapters and fields, rather than using generalized recalls. Original field names and units must also be retained to ensure citation accuracy.

Cross-platform data sources need unified identification rules to avoid citation source confusion.

## Configuration settings
| Configuration Item | Recommended Value | Rationale |
| --- | --- | --- |
| `recall count` | Top 8-12 entries | Biologics financial report documents have many paragraphs. A sufficient number of core data paragraphs must be recalled while avoiding interference from irrelevant content for analysis |
| `similarity threshold` | 0.75-0.85 | Financial reports contain a large number of specialized terms. A higher threshold filters irrelevant recall results and ensures cited content is strongly relevant to the analysis topic |
| `PARSE_SEGMENT_LENGTH` | 1000-1500 characters | Financial report paragraphs have dense data and contain associated fields. This segment length preserves complete professional context and avoids splitting core data |
| `SOURCE_PRIORITY_RULE` | Exchange disclosure platforms > Official investor relations pages > Third-party databases | Exchange disclosure data is legally public information with high authority. Configuring according to this rule prioritizes compliant, official public data for citation |
| `CITE_TEMPLATE` | `{source document name}, {chapter name}, {original field name}` | Biologics financial reports require traceability to specific chapters and fields. This template clearly displays the original information being cited |
| `PARSE_TIMEOUT` | 300 seconds | When batch processing long financial report documents, this duration ensures all data paragraphs are fully parsed and avoids early timeout interruptions |

> The parameter values provided on this page are common starting points for configuration. Actual values are affected by material format, data volume, and business rules. Specific issues require specific analysis. It is recommended to test on your own samples before finalizing settings.

## Three common configuration mistakes
- Phenomenon: Irrelevant third-party database citations appear in generated analysis reports. Cause: The `SOURCE_PRIORITY_RULE` parameter was not configured, causing low-priority data sources to be recalled first.
- Phenomenon: Unnecessary citation markers are retained in exported files and cannot be disabled via configuration. Cause: The `DISABLE_CITE_IN_EXPORT` parameter was not enabled, causing the export process to retain citation identifiers.
- Phenomenon: Cited field names are replaced with generic expressions, such as replacing "batch issuance batch number" with "production quantity". Cause: Original field names were not retained per the `CITE_TEMPLATE` configuration, causing original field information to be lost during parsing.

## How to verify correct configuration
- Upload a publicly available biologics financial report document to trigger knowledge base parsing, then check if parsed paragraphs retain original field names and units.
- Initiate a financial report analysis request, then check if citation sources in the returned results are sorted according to the configured priority.
- Export the analysis report, verify that citation markers conform to the configured `CITE_TEMPLATE` format, and that no extraneous citation content is present.
- Upload a financial report document exceeding 10,000 characters, confirm that no timeout error is triggered during parsing, and verify that the `PARSE_TIMEOUT` configuration takes effect.

> Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-14.
